 |
| Farmingdale,
NY |
 |
| Dublin,
Ireland |
 |
| Singapore |
 |
| India |
|
ICON Central Laboratories, Inc.
is headquartered in Farmingdale, New York. Our company provides
global central laboratory services from core facilities in
New York, Dublin, Singapore and India. Since 2000, we have
successfully managed the laboratory and associated investigator
and logistical support requirements for hundreds of clients
in virtually every phase and therapeutic area of clinical
development.
In addition to being fully accredited
by the College of American Pathologists and holding numerous
other laboratory certifications and licenses, we are pleased
to have been among the first central laboratories to receive
ISO 17025 quality certification.
Our parent company, ICON plc,
is a global provider of outsourced development services to
the pharmaceutical, biotechnology and medical device industries.
The company specializes in the strategic development, management
and analysis of programs that support clinical development
– from compound selection to Phase I-IV clinical studies.
ICON teams have successfully conducted over 5500 development
projects and consultancy engagements across all major therapeutic
areas. ICON currently has over 6500 employees, operating from
72 locations in 38 countries.
Depending upon each client’s
needs and preferences, ICON Central Laboratories can provide
central laboratory support as an individual vendor or as part
of a full service clinical development package with other
divisions of
ICON plc.
ICON Central Laboratories and
its predecessor companies have served the pharmaceutical and
biotechnology industries since the early 1990s. Our company
evolved from NDA Laboratories that was founded in the United
States in 1993 to provide central laboratory support. In 1995,
in response to the industry’s growing need for global
capabilities, NDA Laboratories became part of the larger UK-based
company known as UCTI. In June 2000, ICON
plc bought the U.S. laboratory to complement its central
laboratory based in Dublin Ireland, known as Clinicon.
In 2007, the Singapore office
was added to ICON Central Laboratories owned facilities, providing
accessioning, reporting, sample management and storage services,
and site support in the Asia – Pacific region. Routine
safety testing capabilities are available with plans to expand
testing further in 2009.
In 2008, ICON Central Laboratories
announced the addition of the newest full service laboratory
and site service center in Bangalore, India. The purpose-built,
15,000 square foot facility is in the process of receiving
CAP (College of American Pathologists) and NABL (National
Accreditation Board for Laboratory Testing) accreditation.
Today, ICON Central Laboratories
is regarded as one of the leading central laboratories in
the world.
|